A 50-year-old woman with obesity (BMI 37 kg/m²) and hypertension asks about pharmacologic options for weight loss after unsuccessful lifestyle interve...

Question

A 50-year-old woman with obesity (BMI 37 kg/m²) and hypertension asks about pharmacologic options for weight loss after unsuccessful lifestyle interventions. According to current obesity management frameworks used in Canada, which option is appropriate to consider if no contraindications exist?

Accepted Answer

Evidence-based anti-obesity medications such as GLP-1 receptor agonists as adjuncts to lifestyle

Answer

No pharmacologic therapy should ever be used for obesity

Answer

Short-course systemic steroids to suppress appetite

Answer

Long-term high-dose diuretics

Answer

Thyroid hormone therapy despite normal thyroid function

ca-mccqe1 MCQ (SBA): Pharmacologic obesity treatment

A 50-year-old woman with obesity (BMI 37 kg/m²) and hypertension asks about pharmacologic options for weight loss after unsuccessful lifestyle interventions. According to current obesity management frameworks used in Canada, which option is appropriate to consider if no contraindications exist?